Central Nervous System Pharmacology Practice Questions

Q: All of the following drugs are used in the treatment of dementia except?

Duloxetine. **Explanation:** The treatment of dementia, particularly Alzheimer’s disease, focuses on enhancing cholinergic transmission or modulating glutamatergic excitability. **Why Duloxetine is the correct answer:** **Duloxetine** is a **Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)**. It is primarily used as an antidepressant, anxiolytic, and for the management of chronic pain conditions like diabetic peripheral neuropathy and fibromyalgia. It has **no established role** in the cognitive enhancement or pathophysiology of dementia. **Analysis of incorrect options:** * **Donepezil & Galantamine (Options C & D):** These are **Reversible Acetylcholinesterase Inhibitors (AChEIs)**. By inhibiting the breakdown of acetylcholine in the synaptic cleft, they compensate for the cholinergic deficit seen in Alzheimer’s. They are first-line treatments for mild-to-moderate dementia. (Note: Rivastigmine is another drug in this class). * **Memantine (Option A):** This is an **NMDA receptor antagonist**. It works by blocking pathological "noise" from excessive glutamate stimulation, which prevents excitotoxicity. It is typically used for moderate-to-severe Alzheimer’s, often in combination with Donepezil. **High-Yield Clinical Pearls for NEET-PG:** * **Rivastigmine** is the only AChEI available as a **transdermal patch**, which improves compliance and reduces GI side effects. * **Common Side Effects of AChEIs:** Diarrhea, nausea, and bradycardia (SLUDGE effects). * **Newer Drug:** **Aducanumab** and **Lecanemab** are monoclonal antibodies targeting amyloid-beta plaques, recently approved for early-stage Alzheimer's. * **Vascular Dementia:** Management focuses on controlling risk factors (Aspirin, Statins) rather than specific cognitive enhancers.

Q: Which of the following is NOT a side effect of fenfluramine?

Dizziness. **Explanation:** Fenfluramine is a sympathomimetic amine that was primarily used as an appetite suppressant (anorectic). Its mechanism involves the release of serotonin (5-HT) and inhibition of its reuptake. **Why Dizziness is the correct answer:** While fenfluramine can cause central nervous system effects, **dizziness** is not a characteristic or hallmark side effect associated with its clinical profile or its withdrawal from the market. In fact, unlike other amphetamine derivatives, fenfluramine often causes **sedation** or drowsiness rather than stimulation or dizziness. **Analysis of Incorrect Options:** * **Pulmonary Hypertension:** Fenfluramine is notorious for causing primary pulmonary hypertension (PPH). This occurs due to increased circulating serotonin levels, which cause vasoconstriction and smooth muscle proliferation in the pulmonary vasculature. * **Valvular Defects:** The drug was famously withdrawn from the market (along with dexfenfluramine) because it caused **cardiac valvulopathy** (specifically thickening of the mitral and aortic valves). This is mediated by the activation of **5-HT2B receptors** located on cardiac valves. * **Sudden Deaths:** Due to the severity of pulmonary hypertension and cardiac valvular damage, several cases of sudden cardiac death were reported, leading to its ban by the FDA in 1997. **High-Yield Clinical Pearls for NEET-PG:** * **"Fen-Phen" Combination:** The combination of Fenfluramine and Phentermine was popular for weight loss but led to the "epidemic" of valvular heart disease. * **Current Use:** Low-dose fenfluramine has recently been repurposed and FDA-approved for the treatment of seizures associated with **Dravet syndrome** and **Lennox-Gastaut syndrome**. * **Key Receptor:** Always associate **5-HT2B receptor agonism** with drug-induced valvular heart disease (also seen with Ergotamine and Pergolide).

Q: Selective decrease in IgA is seen with administration of which of the following drugs?

Phenytoin. **Explanation:** **Phenytoin** is a classic hydantoin anticonvulsant known for a unique side effect profile. The selective decrease in **Serum IgA** levels occurs in approximately 20–25% of patients treated with Phenytoin. The underlying mechanism involves the inhibition of B-cell differentiation into IgA-secreting plasma cells. While often asymptomatic, this can occasionally lead to an increased frequency of upper respiratory tract infections or contribute to the development of gingival hyperplasia. **Analysis of Options:** * **Phenytoin (Correct):** It is the only drug among the options consistently associated with selective IgA deficiency. It also causes other immunological effects like the DRESS syndrome and Stevens-Johnson Syndrome (SJS). * **Diazepam & Clonazepam (Incorrect):** These are Benzodiazepines (BZDs) that act via GABA-A receptors. They do not have significant effects on immunoglobulin levels or the humoral immune system. * **Phenobarbitone (Incorrect):** While it is a long-acting barbiturate used for epilepsy, it is not associated with selective IgA deficiency. Its primary side effects include sedation, cognitive impairment, and osteomalacia. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Phenytoin Side Effects (HOT MALAI):** **H**irsutism, **O**steomalacia, **T**eratogenicity (Fetal Hydantoin Syndrome), **M**egaloblastic anemia (due to folate deficiency), **A**taxia, **L**ymphadenopathy, **A**rrhythmias (on rapid IV), **I**nsulin inhibition (hyperglycemia), and **Gingival Hyperplasia**. * Phenytoin follows **Zero-order kinetics** (Capacity-limited elimination) at therapeutic or high concentrations. * It is a potent **Inducer** of Cytochrome P450 enzymes.

Q: Phenytoin therapy may lead to which of the following?

Folic acid deficiency. **Explanation:** **Phenytoin** is a widely used hydantoin derivative for generalized tonic-clonic and partial seizures. The correct answer is **Folic acid deficiency** because phenytoin interferes with the absorption and metabolism of folate. 1. **Why Folic Acid Deficiency is Correct:** Phenytoin inhibits the enzyme **intestinal conjugase**, which is required to break down dietary polyglutamates into monoglutamates for absorption. Additionally, it may induce hepatic enzymes that accelerate folate catabolism. Long-term therapy leads to low serum folate levels in up to 50% of patients, occasionally manifesting as **Megaloblastic Anemia**. 2. **Why Other Options are Incorrect:** * **A. Microcytic anemia:** Phenytoin causes *macrocytic* (megaloblastic) anemia due to folate deficiency, not microcytic anemia (which is typically associated with iron deficiency). * **B. Thrombosis:** Phenytoin does not cause thrombosis. In fact, if used in neonates or during pregnancy (Fetal Hydantoin Syndrome), it can lead to a deficiency of Vitamin K-dependent clotting factors, increasing the risk of **hemorrhage**, not clotting. * **C. Hypercalcemia:** Phenytoin actually causes **Hypocalcemia** and osteomalacia. It induces cytochrome P450 enzymes, leading to increased catabolism of Vitamin D. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Phenytoin Side Effects (HOT MALAI):** **H**irsutism, **O**steomalacia, **T**eratogenicity (Fetal Hydantoin Syndrome), **M**egaloblastic anemia, **A**taxia, **L**ymphadenopathy, **A**rrhythmias (on rapid IV injection), **I**nsulin inhibition (leading to hyperglycemia) and **G**ingival hyperplasia. * **Zero-Order Kinetics:** Phenytoin follows saturation kinetics; a small dose increase can lead to a disproportionate rise in plasma levels and toxicity. * **Drug of Choice:** Phenytoin is a first-line agent for Status Epilepticus (after Benzodiazepines).

Q: A 48-year-old woman presents to a dermatologist for mole removal. She reports a history of allergic reactions to local anesthetics during previous dental procedures. Her dental records indicate that she received procaine for a tooth extraction. Which of the following local anesthetic agents would be appropriate for her current procedure?

Mepivacaine. ### Explanation **1. Why Mepivacaine is Correct:** Local anesthetics (LAs) are classified into two chemical groups: **Esters** and **Amides**. Allergic reactions are significantly more common with **Ester-type** LAs because they are metabolized into **Para-aminobenzoic acid (PABA)**, a known potent allergen. The patient reacted to **Procaine**, which is an Ester. In cases of documented allergy to an Ester, an **Amide-type** LA should be used, as there is no cross-reactivity between the two classes. **Mepivacaine** is an Amide and is therefore safe for this patient. **2. Why Other Options are Incorrect:** * **Benzocaine, Chloroprocaine, and Tetracaine (Options A, B, C):** All three belong to the **Ester group**. Since they all metabolize into PABA, they carry a high risk of cross-reactivity in a patient already allergic to Procaine. **3. NEET-PG High-Yield Pearls:** * **The "i" Rule:** To distinguish the classes, remember that **Amides** have two "i"s in their name (L**i**doca**i**ne, Pr**i**loca**i**ne, Bup**i**vaca**i**ne, Mep**i**vaca**i**ne, Rop**i**vaca**i**ne), while **Esters** have only one "i" (Proca**i**ne, Chloroproca**i**ne, Benzoca**i**ne, Tetraca**i**ne). * **Metabolism:** Esters are metabolized by **plasma pseudocholinesterase**; Amides are metabolized by **liver microsomal enzymes** (CYP450). * **True Allergy:** True IgE-mediated allergy to Amides is extremely rare (<1%). Often, reactions attributed to Amides are actually due to the preservative **Methylparaben** or accidental intravascular injection of epinephrine. * **Mepivacaine Note:** It is unique because it has mild vasoconstrictive properties, often making the addition of epinephrine unnecessary.

Q: A 25-year-old woman is being treated for a laceration to the forearm. Local anesthesia is used prior to suturing. An allergic reaction is most likely to occur with which of the following local anesthetics?

Procaine. **Explanation:** The core concept behind this question is the chemical classification of local anesthetics (LAs) into **Esters** and **Amides**. **Why Procaine is Correct:** Procaine belongs to the **Ester group** of local anesthetics. Esters are metabolized by plasma pseudocholinesterase into **Para-aminobenzoic acid (PABA)**. PABA is a highly antigenic compound and is the primary culprit behind true allergic reactions (Type I or Type IV hypersensitivity) associated with local anesthesia. Therefore, esters have a much higher potential for allergic reactions compared to amides. **Why the Other Options are Incorrect:** * **Lidocaine, Mepivacaine, and Bupivacaine:** These are all **Amide-linked** local anesthetics. Amides are metabolized in the liver and do not produce PABA. True allergic reactions to amides are extremely rare. When they do occur, they are often attributed to preservatives like *methylparaben* rather than the anesthetic drug itself. **High-Yield NEET-PG Pearls:** * **The "i" Rule:** To distinguish between the two classes, remember that **Amides** have two "i"s in their name (L**i**doca**i**ne, Bup**i**vaca**i**ne, Pr**i**loca**i**ne, Rop**i**vaca**i**ne), while **Esters** have only one "i" (Proca**i**ne, Chloroproca**i**ne, Coca**i**ne, Benzoca**i**ne). * **Cross-reactivity:** There is significant cross-reactivity among different Esters (due to the common PABA metabolite), but there is generally no cross-reactivity between Esters and Amides. * **Drug of Choice:** Lidocaine is the most commonly used LA for minor procedures due to its rapid onset and low allergenic potential. Bupivacaine is preferred for longer duration and labor analgesia but carries a higher risk of cardiotoxicity.

Q: Which of the following benzodiazepines is considered comparatively safe in pregnancy?

Lorazepam. Benzodiazepines (BZDs) are generally avoided during pregnancy as they cross the placenta [2] and are associated with risks like "floppy infant syndrome" and neonatal withdrawal [1]. However, when pharmacological intervention is necessary, **Lorazepam** is considered the preferred choice among BZDs. **Why Lorazepam is the correct answer:** Lorazepam belongs to the **LOT** group (Lorazepam, Oxazepam, Temazepam). These drugs are metabolized solely via **Phase II glucuronidation** and do not have active metabolites. This metabolic pathway is less affected by physiological changes in pregnancy compared to Phase I oxidation. Lorazepam has a relatively shorter half-life and lower lipid solubility compared to Diazepam, reducing the risk of significant fetal accumulation. **Analysis of Incorrect Options:** * **Alprazolam:** It is a triazolobenzodiazepine associated with a higher risk of specific teratogenic effects (like cleft lip/palate) if used in the first trimester [3]. It undergoes Phase I metabolism, which can be unpredictable during pregnancy. * **Zolpidem:** While often used for insomnia, Zolpidem is a non-benzodiazepine hypnotic (Z-drug). Although some studies suggest safety, it is not the "standard" BZD answer for this clinical comparison [3]. * **None of the above:** Incorrect, as Lorazepam is clinically recognized as the safest BZD profile in this context. **NEET-PG High-Yield Pearls:** * **Teratogenicity:** BZDs are traditionally Category D [3]. First-trimester use is linked to **cleft lip and palate** [3]. * **Floppy Infant Syndrome:** Characterized by hypotonia, hypothermia, and respiratory depression in neonates born to mothers taking high-dose BZDs near term [1]. * **Metabolism Tip:** Remember **LOT** (Lorazepam, Oxazepam, Temazepam) for patients with liver dysfunction or pregnancy, as they bypass Phase I (CYP450) metabolism.

Q: A compound X decreases the functional activities of several CNS neurotransmitters including dopamine, adrenaline, and serotonin. At high doses, it may cause Parkinsonism-like extrapyramidal system dysfunction. Which of the following can be X?

Reserpine. **Explanation:** The correct answer is **Reserpine**. **Mechanism of Action:** Reserpine is an alkaloid that irreversibly blocks the **Vesicular Monoamine Transporter (VMAT-2)**. This transporter is responsible for pumping monoamines (Dopamine, Noradrenaline, and Serotonin) from the cytoplasm into synaptic vesicles. By blocking VMAT, these neurotransmitters remain in the cytoplasm where they are degraded by the enzyme Monoamine Oxidase (MAO). This leads to a profound **depletion** of monoamine stores in both the central and peripheral nervous systems. **Clinical Correlation:** * **Parkinsonism:** Since Reserpine depletes Dopamine in the nigrostriatal pathway, it can induce drug-induced Parkinsonism (extrapyramidal symptoms). * **Depression:** Depletion of Serotonin and Noradrenaline often leads to severe secondary depression, which is a classic side effect. **Analysis of Incorrect Options:** * **A. Baclofen:** A GABA-B agonist used as a centrally acting muscle relaxant. It does not deplete monoamines. * **B. Diazepam:** A Benzodiazepine that acts as a GABA-A facilitator. It increases the frequency of chloride channel opening but does not affect monoamine storage. * **C. Ketamine:** An NMDA receptor antagonist used as a dissociative anesthetic. It typically increases sympathetic outflow rather than depleting it. **High-Yield Clinical Pearls for NEET-PG:** * **VMAT-1 vs VMAT-2:** Reserpine inhibits both, but VMAT-2 is the primary isoform in the CNS. * **Historical Use:** Formerly used as an antihypertensive and antipsychotic, but now largely obsolete due to CNS side effects. * **Key Side Effects:** Depression (suicidal ideation), Parkinsonism, hyperprolactinemia, and increased gastric acid secretion (peptic ulcers). * **Tetrabenazine:** A related drug that also inhibits VMAT-2 but is reversible; it is used to treat Huntington’s Chorea.

Q: Which of the following drugs is used for the prophylaxis of migraine?

Flunarizine. **Explanation:** The management of migraine is divided into two categories: **Abortive (Acute) therapy** and **Prophylactic (Preventive) therapy**. **Flunarizine (Option B)** is the correct answer because it is a long-acting **calcium channel blocker** specifically used for the prophylaxis of migraine. It works by preventing intracellular calcium overload and has additional antihistaminic and dopamine-antagonizing properties. Prophylaxis is indicated if a patient experiences more than 2-3 attacks per month or if the attacks are severe enough to significantly impair life. **Analysis of Incorrect Options:** * **Diclofenac (Option A):** An NSAID used for the **acute symptomatic relief** of mild-to-moderate migraine attacks. It inhibits prostaglandin synthesis but does not prevent future attacks. * **Sumatriptan (Option C):** A 5-HT$_{1B/1D}$ receptor agonist. It is the **drug of choice for acute severe migraine** attacks. It causes vasoconstriction of dilated cranial vessels but is never used for prophylaxis. * **Dihydroergotamine (Option D):** An ergot alkaloid used for the **acute treatment** of moderate-to-severe migraine. Due to its potent vasoconstrictive side effects and risk of "ergotism," it is generally reserved for patients who do not respond to triptans. **High-Yield NEET-PG Pearls:** * **First-line prophylactic drugs:** Beta-blockers (Propranolol is the most common), Amitriptyline (TCA), and Topiramate/Valproate (Anticonvulsants). * **Flunarizine** is often preferred in patients with co-existing vertigo but should be avoided in patients with a history of depression or Parkinsonism (due to risk of extrapyramidal symptoms). * **Newer Prophylactic Agents:** CGRP antagonists (e.g., Erenumab, Galcanezumab) are high-yield "monoclonal antibody" targets for refractory cases.

Q: Which of the following drugs has no potential for dependence or addiction?

LSD. **Explanation:** The correct answer is **LSD (Lysergic acid diethylamide)**. **1. Why LSD is the correct answer:** LSD is a potent psychedelic (hallucinogen) that acts primarily as a partial agonist at **5-HT2A receptors**. Unlike most drugs of abuse, LSD does **not** stimulate the release of dopamine in the mesolimbic "reward" pathway (the nucleus accumbens). Because it does not trigger this dopaminergic reward mechanism, it does not cause cravings, compulsive drug-seeking behavior, or physical dependence. While users develop rapid **tachyphylaxis** (tolerance), there is no recognized withdrawal syndrome or addiction potential. **2. Why the other options are incorrect:** * **Morphine:** An opioid agonist that causes profound euphoria and physical dependence. Withdrawal is characterized by lacrimation, rhinorrhea, and "gooseflesh" (piloerection). * **Amphetamines:** These increase synaptic dopamine by stimulating release and inhibiting reuptake. They have a very high potential for psychological addiction and can induce a "schizophrenia-like" stimulant psychosis. * **Benzodiazepines:** These act on GABA-A receptors. Chronic use leads to down-regulation of receptors, resulting in physical dependence and a potentially life-threatening withdrawal syndrome (seizures and delirium). **High-Yield Clinical Pearls for NEET-PG:** * **Hallucinogen Persisting Perception Disorder (HPPD):** A unique long-term complication of LSD where "flashbacks" occur long after the drug has cleared. * **Bad Trip Management:** The first-line treatment for acute LSD intoxication/panic is reassurance ("talking down") and Benzodiazepines if necessary. * **Tolerance:** LSD shows **cross-tolerance** with other hallucinogens like Psilocybin and Mescaline.

Question 1

All of the following drugs are used in the treatment of dementia except?

Accepted Answer

Duloxetine

Answer

Memantine

Answer

Galantamine

Answer

Donepezil

Question 2

Which of the following is NOT a side effect of fenfluramine?

Accepted Answer

Dizziness

Answer

Pulmonary hypertension

Answer

Valvular defects

Answer

Sudden deaths

Question 3

Selective decrease in IgA is seen with administration of which of the following drugs?

Accepted Answer

Phenytoin

Answer

Diazepam

Answer

Clonazepam

Answer

Phenobarbitone

Question 4

Phenytoin therapy may lead to which of the following?

Accepted Answer

Folic acid deficiency

Answer

Microcytic anemia

Answer

Thrombosis

Answer

Hypercalcemia

Question 5

A 48-year-old woman presents to a dermatologist for mole removal. She reports a history of allergic reactions to local anesthetics during previous dental procedures. Her dental records indicate that she received procaine for a tooth extraction. Which of the following local anesthetic agents would be appropriate for her current procedure?

Accepted Answer

Mepivacaine

Answer

Benzocaine

Answer

Chloroprocaine

Answer

Tetracaine

Question 6

A 25-year-old woman is being treated for a laceration to the forearm. Local anesthesia is used prior to suturing. An allergic reaction is most likely to occur with which of the following local anesthetics?

Accepted Answer

Procaine

Answer

Lidocaine

Answer

Mepivacaine

Answer

Bupivacaine

Question 7

Which of the following benzodiazepines is considered comparatively safe in pregnancy?

Accepted Answer

Lorazepam

Answer

Alprazolam

Answer

Zolpidem

Answer

None of the above

Question 8

A compound X decreases the functional activities of several CNS neurotransmitters including dopamine, adrenaline, and serotonin. At high doses, it may cause Parkinsonism-like extrapyramidal system dysfunction. Which of the following can be X?

Accepted Answer

Reserpine

Answer

Baclofen

Answer

Diazepam

Answer

Ketamine

Question 9

Which of the following drugs is used for the prophylaxis of migraine?

Accepted Answer

Flunarizine

Answer

Diclofenac

Answer

Sumatriptan

Answer

Dihydroergotamine

Question 10

Which of the following drugs has no potential for dependence or addiction?

Accepted Answer

LSD

Answer

Morphine

Answer

Amphetamines

Answer

Benzodiazepines

Central Nervous System Pharmacology — MCQs

Central Nervous System Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?